Opko Health, Inc.
OPK
$1.38
-$0.02-1.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.31% | -13.78% | -17.41% | -17.94% | -17.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.31% | -13.78% | -17.41% | -17.94% | -17.48% |
| Cost of Revenue | -7.72% | -5.36% | -5.53% | -0.03% | -4.50% |
| Gross Profit | -4.77% | -42.34% | -50.42% | -64.80% | -54.79% |
| SG&A Expenses | -0.07% | -0.66% | 1.22% | 2.78% | -8.09% |
| Depreciation & Amortization | -5.65% | -5.74% | -3.95% | -2.70% | -1.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.34% | -4.01% | -3.41% | 0.58% | -5.30% |
| Operating Income | 0.06% | -35.25% | -73.07% | -108.98% | -56.45% |
| Income Before Tax | 37.67% | 99.77% | 94.37% | 44.96% | 6.67% |
| Income Tax Expenses | 1,664.42% | 1,972.44% | 865.58% | 343.56% | 97.03% |
| Earnings from Continuing Operations | 27.13% | 84.55% | 71.82% | 35.58% | -16.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.13% | 84.55% | 71.82% | 35.58% | -16.19% |
| EBIT | 0.06% | -35.25% | -73.07% | -108.98% | -56.45% |
| EBITDA | -4.47% | -83.70% | -232.41% | -394.77% | -153.41% |
| EPS Basic | 29.83% | 82.79% | 70.51% | 33.68% | -18.95% |
| Normalized Basic EPS | 22.68% | 75.82% | 61.28% | -9.83% | 17.10% |
| EPS Diluted | 28.30% | 80.87% | 68.04% | 31.22% | -19.95% |
| Normalized Diluted EPS | 19.99% | 72.97% | 57.27% | 3.58% | 17.10% |
| Average Basic Shares Outstanding | -2.62% | -7.48% | -7.68% | -5.15% | -3.22% |
| Average Diluted Shares Outstanding | 17.29% | 12.07% | 11.58% | 4.96% | -3.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |